Flickthrough
Sign Up View Online
Dec 16 2020 . ISSUE 33
THE DAILY NEWSLETTER

Good morning folks! Dont forget, Mrs Bector has gone wild but Nifty is so stubborn at the top. Wishing you some great trades today :)


The stock market is filled with individuals who know the price of everything, but the value of nothing.


– Phillip Fisher


GAINERS & LOSERS

NIFTY

13567.90

+ 9.70

SENSEX

46263.17

+ 9.71

CRUDE OIL

3,488.00

+ 53.00

GOLD

49,470.00

+ 531.00

HOT STOCKS IN NEWS

Majesco announces dividend of Rs 974 per share.The smallcap insurance technology firm has fixed December 25 as record date.

Wonderla Kochi to reopen for public from 24th December onwards.Visitors can enjoy a special reopening offer of Rs. 699 inclusive of GST, with access to all rides, unlimited times.

DAILY FLICKS
Infosys open to work with stakeholders for vaccine management solution
Documents in a folder with Trump Organization insignia

The latest to get on the Covid vaccine bandwagon is IT giants Infosys as they are offering cloud service to keep track of the vaccine management. 


Vaccine Management Solution  


The Tata Group was among the many suitors who have submitted preliminary bids for the government stake in the Airlines. Infosys is gearing up to talk with Indian and foreign government agencies and industry bodies to provide its vaccine management cloud solution that was rolled out last month. 


Simplus, a subsidiary of Infosys, in collaboration with Salesforce developed a state of the art vaccine management cloud solution. It helps in covering a wide range of activities such as campaign management, citizen registration, prioritisation, provider enrollment etc. 


Infosys is trying to take this system to commercial level and thus have approached government agencies and industrial houses. 


Bottom line: This tool would turn out to be quite useful given the gargantuan population density of India. 

Biocon Biologics inks pact with CSSC in Tanzania for its ‘Mission 10 cents’
walmart shopping

The 'Mission 10 cents' is coming to Africa, and it's sure to help thousands of underprivileged and malnutritioned. 


Cheap insulin for Tanzania 


Biotechnology major Biocon has announced that its arm Biocon Biologics has signed a pact with the Christian Social Services Commission (CSSC) in Tanzania, in continuation of its ‘Mission 10 cents’, an affordable insulin programme for low- and middle-income countries.


Tanzania will be the first country in Africa that will benefit from this collaboration  The programme is expected to roll out early next year and will include community-based health promotion, disease awareness campaigns, screening programmes etc.


What is 'Mission 10 cents'? 


The 'Mission 10 cents' by Biocon Biologics is helping unlock universal access to quality insulins in low- and middle-income countries (LMICs) for less than 10 US cents per day. 


Bottom line: A truly humanitarian move by Biocon. 


Bharat Petroleum to consider buying Oman Oil stake in Bina refinery
walmart shopping

Privatisation-bound Bharat Petroleum Corporation Ltd's (BPCL) board will consider buying out Oman Oil Company stake in the Bina refinery project in Madhya Pradesh. 


Buying it out  


BPCL holds 63.68% stake in Bharat Oman Refineries Ltd (BORL), and is considering to put in an offer for the acquisition of the remaining 36.62% stake owned by S.A.O.C (formerly known as Oman Oil Company S.A.O.C).


BPCL holds 63.68% stake in Bharat Oman Refineries Ltd (BORL), and is considering to put in an offer for the acquisition of the remaining 36.62% stake owned by S.A.O.C (formerly known as Oman Oil Company S.A.O.C).


Possible Merger? 


BPCL board will also consider merging Bharat Gas Resources Ltd(BGRL) with itself. BPCL had incorporated BGRL for handling the natural gas business in June 2018. 


Bottom line: if the acquisition & merger goes through, the prospective bidders of BPCL will be licking their lips and revising their bid.  


OTHER FLICKS
  • M&M to increase the price of vehicles from Jan 1, 2021.The company will increase the price of its range of Passenger and Commercial Vehicles, across models. This has been necessitated due to the increase in commodity prices and various other input costs.
  • Moderna's COVID-19 vaccine clears first US FDA hurdle. FDA staff said a two-dose regimen of Moderna's vaccine was highly effective in preventing confirmed cases of COVID-19.
fb   tw   yt
PRIVACY STATEMENT | TERMS OF SERVICE | RETURNS
© 2020 Flickthrough. All Rights Reserved.
If you do not wish to receive any further emails from us, please unsubscribe
  Never miss a story from us, get daily market updates in your inbox.